BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9098095)

  • 1. Evaluation of tempol radioprotection in a murine tumor model.
    Hahn SM; Sullivan FJ; DeLuca AM; Krishna CM; Wersto N; Venzon D; Russo A; Mitchell JB
    Free Radic Biol Med; 1997; 22(7):1211-6. PubMed ID: 9098095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential radiation protection of salivary glands versus tumor by Tempol with accompanying tissue assessment of Tempol by magnetic resonance imaging.
    Cotrim AP; Hyodo F; Matsumoto K; Sowers AL; Cook JA; Baum BJ; Krishna MC; Mitchell JB
    Clin Cancer Res; 2007 Aug; 13(16):4928-33. PubMed ID: 17699873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the hydroxylamine Tempol-H as an in vivo radioprotector.
    Hahn SM; Krishna MC; DeLuca AM; Coffin D; Mitchell JB
    Free Radic Biol Med; 2000 Mar; 28(6):953-8. PubMed ID: 10802227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo radioprotection and effects on blood pressure of the stable free radical nitroxides.
    Hahn SM; DeLuca AM; Coffin D; Krishna CM; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):839-42. PubMed ID: 9845107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tempol, a stable free radical, is a novel murine radiation protector.
    Hahn SM; Tochner Z; Krishna CM; Glass J; Wilson L; Samuni A; Sprague M; Venzon D; Glatstein E; Mitchell JB
    Cancer Res; 1992 Apr; 52(7):1750-3. PubMed ID: 1551104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential use of nitroxides in radiation oncology.
    Hahn SM; Krishna CM; Samuni A; DeGraff W; Cuscela DO; Johnstone P; Mitchell JB
    Cancer Res; 1994 Apr; 54(7 Suppl):2006s-2010s. PubMed ID: 8137329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing nitroxide reduction and cytotoxicity in vitro.
    Samuni Y; Gamson J; Samuni A; Yamada K; Russo A; Krishna MC; Mitchell JB
    Antioxid Redox Signal; 2004 Jun; 6(3):587-95. PubMed ID: 15130285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The stable nitroxide tempol facilitates salivary gland protection during head and neck irradiation in a mouse model.
    Vitolo JM; Cotrim AP; Sowers AL; Russo A; Wellner RB; Pillemer SR; Mitchell JB; Baum BJ
    Clin Cancer Res; 2004 Mar; 10(5):1807-12. PubMed ID: 15014035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection from lethal irradiation by the combination of stem cell factor and tempol.
    Liebmann J; DeLuca AM; Epstein A; Steinberg SM; Morstyn G; Mitchell JB
    Radiat Res; 1994 Mar; 137(3):400-4. PubMed ID: 7511822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor growth and tumor radiosensitivity in mice given myeloprotective doses of fibroblast growth factors.
    Ding I; Huang K; Snyder ML; Cook J; Zhang L; Wersto N; Okunieff P
    J Natl Cancer Inst; 1996 Oct; 88(19):1399-404. PubMed ID: 8827018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection from radiation-induced chromosomal aberrations by the nitroxide Tempol.
    Johnstone PA; DeGraff WG; Mitchell JB
    Cancer; 1995 May; 75(9):2323-7. PubMed ID: 7712443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, tempol.
    Mitchell JB; DeGraff W; Kaufman D; Krishna MC; Samuni A; Finkelstein E; Ahn MS; Hahn SM; Gamson J; Russo A
    Arch Biochem Biophys; 1991 Aug; 289(1):62-70. PubMed ID: 1654848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of tempol for prevention of xerostomia following head and neck irradiation in a mouse model.
    Cotrim AP; Sowers AL; Lodde BM; Vitolo JM; Kingman A; Russo A; Mitchell JB; Baum BJ
    Clin Cancer Res; 2005 Oct; 11(20):7564-8. PubMed ID: 16243832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oxygen challenging to tissue redox and pO
    Matsumoto KI; Mitchell JB; Krishna MC
    Free Radic Biol Med; 2019 Jan; 130():343-347. PubMed ID: 30391676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the intracellular redox status of tumors with magnetic resonance imaging and redox-sensitive contrast agents.
    Hyodo F; Matsumoto K; Matsumoto A; Mitchell JB; Krishna MC
    Cancer Res; 2006 Oct; 66(20):9921-8. PubMed ID: 17047054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of nitroxide radioprotectors.
    Hahn SM; Wilson L; Krishna CM; Liebmann J; DeGraff W; Gamson J; Samuni A; Venzon D; Mitchell JB
    Radiat Res; 1992 Oct; 132(1):87-93. PubMed ID: 1410280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical application of nitroxide protects radiation-induced alopecia in guinea pigs.
    Goffman T; Cuscela D; Glass J; Hahn S; Krishna CM; Lupton G; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1992; 22(4):803-6. PubMed ID: 1544853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TEMPOL protects against lens DNA strand breaks and cataract in the x-rayed rabbit.
    Sasaki H; Lin LR; Yokoyama T; Sevilla MD; Reddy VN; Giblin FJ
    Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):544-52. PubMed ID: 9501865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of stable nitroxide, 3-substituted 2,2,5,5-tetramethylpyrrolidine-N-oxyls, with respect to protection from radiation, prevention of DNA damage, and distribution in mice.
    Anzai K; Ueno M; Yoshida A; Furuse M; Aung W; Nakanishi I; Moritake T; Takeshita K; Ikota N
    Free Radic Biol Med; 2006 Apr; 40(7):1170-8. PubMed ID: 16545684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo topical EPR spectroscopy and imaging of nitroxide free radicals and polynitroxyl-albumin.
    Kuppusamy P; Wang P; Shankar RA; Ma L; Trimble CE; Hsia CJ; Zweier JL
    Magn Reson Med; 1998 Dec; 40(6):806-11. PubMed ID: 9840823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.